iral Meningitis Awareness Week runs from 1–7 May. Now in its sixth year, the UK charity, Meningitis Now have themed their 2018 campaign ‘Make Viral Visible.’
The FDA has cleared the Elecsys HSV-1 IgG and HSV-2 IgG assays, from Roche, for detecting Herpes Simplex virus (HSV)...
Varicella zoster virus (VZV) infections – herpes zoster Famvir is indicated for - the treatment of herpes zoster and ophthalmic zoster in immunocompetent adults (see section 4.4) - the treatment of herpes zoster in immunocompromised adults (see section 4.4) Herpes simplex virus (HSV) infections – genital herpes Famvir is indicated for - the treatment of first and recurrent episodes of genital herpes in immunocompetent adults - the treatment of recurrent episodes of genital herpes in immunocompromised adults - the suppression of recurrent genital herpes in immunocompetent and immunocompromised adults Clinical studies have not been conducted in HSV-infected patients immunocompromised for other causes than HIV-infection (see section 5.1).
Objectives: To determine, in a European cohort, the prevalence and health-related quality-of-life (QOL) burden of moderate-to-severe vasomotor symptoms (VMS) in postmenopausal women, and among subgroups of women not taking hormone therapy (HT).
Varicella zoster virus (VZV) infections – herpes zoster Valaciclovir is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults (see section 4.4). Valaciclovir is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression (see section 4.4). Herpes simplex virus (HSV) infections Valaciclovir is indicated • for the treatment and suppression of HSV infections of the skin and mucous membranes including: - treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults - treatment of recurrences of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults - suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adults. • Treatment and suppression of recurrent ocular HSV infections in immunocompetent adults and adolescents and in immunocompromised adults (see section 4.4) Clinical studies have not been conducted in HSV-infected patients immunocompromised for other causes than HIV-infection (see section 5.1). Cytomegalovirus (CMV) infections : Valaciclovir is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents (see section 4.4)
Varicella zoster virus (VZV) infections – herpes zoster Valaciclovir is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults (see section 4.4). Valaciclovir is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression (see section 4.4). Herpes simplex virus (HSV) infections Valaciclovir is indicated • for the treatment and suppression of HSV infections of the skin and mucous membranes including - treatment of first-episode of genital herpes in immunocompetent patients - recurrences of genital herpes in immunocompetent and immunocompromised patients - suppression of recurrent genital herpes in immunocompetent and immunocompromised patients • Treatment and suppression of recurrent ocular HSV infections (see section 4.4) Clinical studies have not been conducted in HSV-infected patients immunocompromised for other causes than HIV-infection (see section 5.1). Cytomegalovirus (CMV) infections Valaciclovir is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents (see section 4.4)
Varicella zoster virus (VZV) infections – herpes zoster Valtrex is indicated for the treatment of herpes zoster (shingles) and ophthalmic zoster in immunocompetent adults (see sections 4.4). Valtrex is indicated for the treatment of herpes zoster in adult patients with mild or moderate immunosuppression (see section 4.4). Herpes simplex virus (HSV) infections Valtrex is indicated • for the treatment and suppression of HSV infections of the skin and mucous membranes including: - treatment of first-episode of genital herpes in immunocompetent adults and adolescents and in immunocompromised adults - treatment of recurrences of genital herpes in immunocompetent adults and adolescents, and in immunocompromised adults - suppression of recurrent genital herpes in immunocompetent adults and adolescents and in immunocompromised adults • Treatment and suppression of recurrent ocular HSV infections in immunocompetent adults and adolescents and in immunocompromised adults (see section 4.4) Clinical studies have not been conducted in HSV-infected patients immunocompromised for other causes than HIV-infection (see section 5.1). Cytomegalovirus (CMV) infections Valtrex is indicated for the prophylaxis of CMV infection and disease following solid organ transplantation in adults and adolescents (see section 4.4)